Last updated on August 2019

Low-dose Atropine for the Prevention of Myopia Progression in Danish Children


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Myopia
  • Age: Between 6 - 12 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Children aged 6-<9 years: myopia -1 (spherical equivalent) in at least one eye
  • Children aged 9-12 years: myopia -2 (spherical equivalent) in at least one eye
  • Cylinder less than 1.5 diopters

Exclusion Criteria:

  • Myopia related to retinal dystrophies
  • Collagen syndroms (Ehlers-Danlos syndrome, Marfan syndrome and Stickler syndrome)
  • Other ocular pathology (e.g., amblyopia, strabismus)
  • Previous eye surgery
  • Previous use of agents thought to affect myopia progression, e.g. atropine, pirenzepine or 7-methylxanthine (metabolite of caffeine and theobromine) and orthokeratology contact lenses
  • Known allergy to atropine or any of the contents of the trial medication (active and in-active ingredients) used in the study
  • Non-compliance to eye examinations
  • Serious systemic health troubles (e.g., cardiac or respiratory illness) and developmental disorders and delays

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.